Prof. Raoult MD, PhD at Aix-Marseille University discusses the latest results of his treatment with Hydroxychloroquine + Azithromycin of over 2600 patients with Covid-19.
He also discusses his views on the use of the drug Remdesivir, and the impact of medical news on the performance of stocks Gilead and Sanofi..